Memantine prevents cognitive impairment and reduces Bcl-2 and caspase 8 immunoreactivity in rats injected with amyloid β1-40

European Journal of Pharmacology

Volumn 692, Issue 1-3, 2012, Pages 38-45

  Javier Miguel Hidalgo, José ^a   Paul, Ian A ^a   Wanzo, Valerie ^a   Banerjee, Pradeep K ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

Author keywords

Amyloid; Apoptosis; Bcl 2; Caspase 8; Memantine; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; CASPASE 3; CASPASE 6; CASPASE 8; CASPASE 9; MEMANTINE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; IMMUNOREACTIVITY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TREATMENT RESPONSE;

EID: 84865865850     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.07.032     Document Type: Article

References (52)

1. A. Awasthi, Y. Matsunaga, and T. Yamada Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides Exp. Neurol. 196 2005 282 289
2. D.E. Bredesen, R.V. Rao, and P. Mehlen Cell death in the nervous system Nature 443 2006 796 802
3. J.R. Brorson, V.P. Bindokas, T. Iwama, C.J. Marcuccilli, J.C. Chisholm, and R.J. Miller The Ca2 influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation J. Neurobiol. 26 1995 325 338
4. J. Busciglio, J. Yeh, and B.A. Yankner beta-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins J. Neurochem. 61 1993 1565 1568
5. B. Cai, S.H. Chang, E.B. Becker, A. Bonni, and Z. Xia p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65 J. Biol. Chem. 281 2006 25215 25222
6. R.F. Cowburn, B. Wiehager, E. Trief, M. Li-Li, and E. Sundstrom Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor Neurochem. Res. 22 1997 1437 1442
7. C. Culmsee, and S. Landshamer Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders Curr. Alzheimer Res. 3 2006 269 283
8. W. Danysz, and C.G. Parsons The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence Int. J. Geriatr. Psychiatry 18 2003 S23 32
9. W. Danysz, C.G. Parsons, H.J. Mobius, A. Stoffler, and G. Quack Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease - a unified glutamatergic hypothesis on the mechanism of action Neurotox. Res. 2 2000 85 97
10. E. Engidawork, T. Gulesserian, R. Seidl, N. Cairns, and G. Lubec Expression of apoptosis related proteins in brains of patients with Alzheimer's disease Neurosci. Lett. 303 2001 79 82
11. E. Engidawork, T. Gulesserian, B.C. Yoo, N. Cairns, and G. Lubec Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease Biochem. Biophys. Res. Commun. 281 2001 84 93
12. B. Fadeel, B. Zhivotovsky, and S. Orrenius All along the watchtower: on the regulation of apoptosis regulators FASEB J. 13 1999 1647 1657
13. M.P. Fogarty, E.J. Downer, and V. Campbell A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons Biochem. J. 371 2003 789 798
14. P. Fuentes-Prior, and G.S. Salvesen The protein structures that shape caspase activity, specificity, activation and inhibition Biochem. J. 384 2004 201 232
15. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112
16. T. Harkany, I. Abraham, W. Timmerman, G. Laskay, B. Toth, M. Sasvari, C. Konya, J.B. Sebens, J. Korf, C. Nyakas, M. Zarandi, K. Soos, B. Penke, and P.G. Luiten beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis Eur. J. Neurosci. 12 2000 2735 2745
17. K. Iwasaki, T. Sunderland, J.W. Kusiak, and B. Wolozin Changes in gene transcription during a beta-mediated cell death Mol. Psychiatry 1 1996 65 71
18. K.A. Jellinger Challenges in neuronal apoptosis Curr. Alzheimer Res. 3 2006 377 391
19. B.L. Kelly, and A. Ferreira beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-d-aspartate receptors in hippocampal neurons J. Biol. Chem. 281 2006 28079 28089
20. J.Y. Koh, L.L. Yang, and C.W. Cotman Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage Brain Res. 533 1990 315 320
21. A. LeBlanc, H. Liu, C. Goodyer, C. Bergeron, and J. Hammond Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease J. Biol. Chem. 274 1999 23426 23436
22. R. Li, L. Yang, K. Lindholm, Y. Konishi, X. Yue, H. Hampel, D. Zhang, and Y. Shen Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death J. Neurosci. 24 2004 1760 1771
23. C.M. Luetjens, S. Lankiewicz, N.T. Bui, A.J. Krohn, M. Poppe, and J.H. Prehn Up-regulation of Bcl-xL in response to subtoxic beta-amyloid: role in neuronal resistance against apoptotic and oxidative injury Neuroscience 102 2001 139 150
24. G.A. MacGibbon, P.A. Lawlor, E.S. Sirimanne, M.R. Walton, B. Connor, D. Young, C. Williams, P. Gluckman, R.L. Faull, P. Hughes, and M. Dragunow Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus Brain Res. 750 1997 223 234
25. H. Martinez-Coria, K.N. Green, L.M. Billings, M. Kitazawa, M. Albrecht, G. Rammes, C.G. Parsons, S. Gupta, P. Banerjee, and F.M. LaFerla Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice Am. J. Pathol. 176 2009 870 880
26. M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R.E. Rydel Beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J. Neurosci. 12 1992 376 389
27. J.J. Miguel-Hidalgo, X.A. Alvarez, R. Cacabelos, and G. Quack Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40) Brain Res. 958 2002 210 221
28. J.J. Miguel-Hidalgo, and R. Cacabelos Beta-amyloid(1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield Acta Neuropathol. (Berlin) 95 1998 455 465
29. A.M. Minogue, A.W. Schmid, M.P. Fogarty, A.C. Moore, V.A. Campbell, C.E. Herron, and M.A. Lynch Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1beta? J. Biol. Chem. 278 2003 27971 27980
30. H.J. Mobius, A. Stoffler, and S.M. Graham Memantine hydrochloride: pharmacological and clinical profile Drugs Today (Barcelona) 40 2004 685 695
31. Z. Molnar, K. Soos, I. Lengyel, B. Penke, V. Szegedi, and D. Budai Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo Neuroreport 15 2004 1649 1652
32. S. Nakamura, N. Murayama, T. Noshita, R. Katsuragi, and T. Ohno Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801 Eur. J. Pharmacol. 548 2006 115 122
33. D.S. Olton, and R.L. Isaacson Hippocampal lesions and active avoidance Physiol. Behav. 3 1968 719 724
34. M. Overmyer, M. Kraszpulski, S. Helisalmi, H. Soininen, and I. Alafuzoff DNA fragmentation, gliosis and histological hallmarks of Alzheimer's disease Acta Neuropathol. (Berlin) 100 2000 681 687
35. E. Paradis, H. Douillard, M. Koutroumanis, C. Goodyer, and A. LeBlanc Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons J. Neurosci. 16 1996 7533 7539
36. C.G. Parsons, W. Danysz, and G. Quack Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data Neuropharmacology 38 1999 735 767
37. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 4th ed. 1998 Academic Press San Diego
38. E.R. Peskind, S.G. Potkin, N. Pomara, B.R. Ott, S.M. Graham, J.T. Olin, and S. McDonald Memantine treatment in mild to moderate Alzheimer Disease: a 24-week randomized, controlled trial Am. J. Geriatr. Psychiatry 2006
39. O.A. Ramirez, and H.F. Carrer Correlation between threshold to induce long-term potentiation in the hippocampus and performance in a shuttle box avoidance response in rats Neurosci. Lett. 104 1989 152 156
40. B. Reisberg, R. Doody, A. Stoffler, F. Schmitt, S. Ferris, and H.J. Mobius Memantine in moderate-to-severe Alzheimer's disease N. Engl. J. Med. 348 2003 1333 1341
41. T.T. Rohn, E. Head, W.H. Nesse, C.W. Cotman, and D.H. Cribbs Activation of caspase-8 in the Alzheimer's disease brain Neurobiol. Dis. 8 2001 1006 1016
42. F.D. Sajan, F. Martiniuk, D.L. Marcus, W.H. Frey 2nd, R. Hite, E.Z. Bordayo, and M.L. Freedman Apoptotic gene expression in Alzheimer's disease hippocampal tissue Am. J. Alzheimers Dis. Other Demen. 22 2007 319 328
43. S. Shimohama Apoptosis in Alzheimer's disease - an update Apoptosis 5 2000 9 16
44. J.H. Su, A.J. Anderson, D.H. Cribbs, C. Tu, L. Tong, P. Kesslack, and C.W. Cotman Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death Neurobiol. Dis. 12 2003 182 193
45. J.H. Su, T. Satou, A.J. Anderson, and C.W. Cotman Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease Neuroreport 7 1996 437 440
46. R. Tremblay, B. Chakravarthy, K. Hewitt, J. Tauskela, P. Morley, T. Atkinson, and J.P. Durkin Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals J. Neurosci. 20 2000 7183 7192
47. G.L. Wenk, C.G. Parsons, and W. Danysz Potential role of N-methyl-d-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine Behav. Pharmacol. 17 2006 411 424
48. A. Woodhouse, T.C. Dickson, A.K. West, C.A. McLean, and J.C. Vickers No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases Neurobiol. Dis. 22 2006 323 333
49. D.S. Yang, A. Kumar, P. Stavrides, J. Peterson, C.M. Peterhoff, M. Pawlik, E. Levy, A.M. Cataldo, and R.A. Nixon Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease Am. J. Pathol. 173 2008 665 681
50. J. Yuan, and B.A. Yankner Apoptosis in the nervous system Nature 407 2000 802 809
51. W. Zajaczkowski, M. Hetman, E. Nikolaev, G. Quack, W. Danysz, and L. Kaczmarek Behavioural evaluation of long-term neurotoxic effects of NMDA receptor antagonists Neurotox. Res. 1 2000 299 310
52. P.R. Zoladz, A.M. Campbell, C.R. Park, D. Schaefer, W. Danysz, and D.M. Diamond Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane Pharmacol. Biochem. Behav. 85 2006 298 306